Cerus Corp (NASDAQ:CERS)

During the Trading Day
3.71 +0.07 / +1.92%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.71 0.00 / 0.00%
 
Volume: 12.3K
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$269.5M

Company Description

Cerus Corp. is a biomedical products company, which is engaged in developing and commercializing the INTERCEPT blood system. It currently markets and sells the INTERCEPT blood system for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Contact Information

Cerus Corp.
2550 Stanwell Drive
Concord California 94520
P:(925) 288-6000
Investor Relations:
(925) 288-6319

Employees

Shareholders

Individual stakeholders5.96%
Other institutional35.47%
Mutual fund holders25.23%

Top Executives

William Mariner GreenmanPresident, Chief Executive Officer & Director
Suzanne MargerumVice President-Manufacturing & Operations
Kevin Dennis GreenChief Financial Officer & Vice President
Laurence M. CorashDirector, SVP, Chief Scientific & Medical Officer
Adonis StassinopoulosVP-Global Scientific Affairs & Research

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.